Endpoints at 30 and 180 days in the whole cohort
| Cohort B | Cohort H | P value | |
| Death 30 days | 62 (9.4%) | 56 (8.9%) | 0.77 |
| Death 180 days | 73 (11.0%) | 71 (11.3%) | 0.88 |
| CVA 30 days | 5 (0.8%) | 3 (0.5%) | 0.52 |
| TLF 30 days | 12 (1.8%) | 11 (1.8%) | 0.93 |
| Definite ST 30 days | 3 (0.5%) | 2 (0.3%) | 0.70 |
| Bleeding all 30 days | 145 (21.9%) | 138 (21.9%) | 0.99 |
| Bleeding BARC≥2 30 days | 102 (15.4%) | 115 (18.3%) | 0.17 |
| Bleeding BARC 2 30 days | 82 (12.4%) | 99 (15.7%) | 0.09 |
| Bleeding BARC 3 30 days | 17 (2.6%) | 15 (2.4%) | 0.83 |
| Bleeding BARC 4 30 days | 1 | 0 | – |
| Bleeding BARC 5 30 days | 2 | 1 | – |
CVA, cerebrovascular accident; ST, stent thrombosis; TLF, target lesion failure.